Leveraging EEG for Antidepressant Prediction With Duloxetine and Bupropion

clinical trial

Leveraging EEG for Antidepressant Prediction With Duloxetine and Bupropion is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT04388189

P6099clinical trial phasephase IV clinical trialQ42825046
P582end time2023-05-30
P921main subject(S)-duloxetineQ411932
P4135maximum age85
P2899minimum age22
P1132number of participants200
P4844research interventionbupropionQ834280
duloxetine hydrochlorideQ27116971
P8005research subject recruitment statusnot yet recruitingQ76649614
P1813short nameLEAP-DB
P580start time2020-06-01
P8363study typeinterventional studyQ78089383
P1476titleLeveraging EEG for Antidepressant Prediction With Duloxetine and Bupropion (LEAP-DB): A Multicenter, Randomized, Blinded Outcome Study of EEG-guided Treatment With Duloxetine Versus Bupropion in Adults With Major Depressive Disorder